Shinya Fujisawa

988 total citations
35 papers, 788 citations indexed

About

Shinya Fujisawa is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Shinya Fujisawa has authored 35 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 16 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Shinya Fujisawa's work include Chronic Myeloid Leukemia Treatments (9 papers), Acute Myeloid Leukemia Research (6 papers) and Retinoids in leukemia and cellular processes (6 papers). Shinya Fujisawa is often cited by papers focused on Chronic Myeloid Leukemia Treatments (9 papers), Acute Myeloid Leukemia Research (6 papers) and Retinoids in leukemia and cellular processes (6 papers). Shinya Fujisawa collaborates with scholars based in Japan, Nigeria and United States. Shinya Fujisawa's co-authors include Kazunori Ohnishi, Kensuke Naito, Akihiro Takeshita, Kohichiro Shigeno, Shota Nakamura, Kaori Shinjo, Kaori Takeshita, Kazuyuki Shigeno, Satoki Nakamura and Naruhiko Sahara and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Shinya Fujisawa

34 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shinya Fujisawa Japan 14 491 323 199 101 83 35 788
Laura Cicconi Italy 18 662 1.3× 432 1.3× 118 0.6× 85 0.8× 66 0.8× 32 918
Nélida I. Noguera Italy 18 631 1.3× 511 1.6× 62 0.3× 167 1.7× 75 0.9× 55 976
Yi-Cheng Wang United States 12 276 0.6× 288 0.9× 90 0.5× 55 0.5× 50 0.6× 15 517
Montreh Tavakkoli United States 8 410 0.8× 195 0.6× 118 0.6× 25 0.2× 98 1.2× 25 638
Tiziana Ottone Italy 23 825 1.7× 660 2.0× 159 0.8× 158 1.6× 120 1.4× 63 1.2k
R. Serafini Italy 13 474 1.0× 198 0.6× 239 1.2× 64 0.6× 91 1.1× 29 888
Kwan Yeung Wong Hong Kong 23 1.0k 2.1× 276 0.9× 151 0.8× 90 0.9× 105 1.3× 37 1.4k
R. Hafter Germany 15 109 0.2× 244 0.8× 110 0.6× 54 0.5× 34 0.4× 49 704
Lingbo Zhang China 14 398 0.8× 162 0.5× 83 0.4× 132 1.3× 88 1.1× 27 894
Urszula Kralisz Poland 8 255 0.5× 325 1.0× 46 0.2× 44 0.4× 153 1.8× 18 729

Countries citing papers authored by Shinya Fujisawa

Since Specialization
Citations

This map shows the geographic impact of Shinya Fujisawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinya Fujisawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinya Fujisawa more than expected).

Fields of papers citing papers by Shinya Fujisawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinya Fujisawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinya Fujisawa. The network helps show where Shinya Fujisawa may publish in the future.

Co-authorship network of co-authors of Shinya Fujisawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shinya Fujisawa. A scholar is included among the top collaborators of Shinya Fujisawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinya Fujisawa. Shinya Fujisawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Tomohiro, Yu Kaneko, Hirotaka Yamamoto, et al.. (2025). Development of a novel anti-erythropoietin-producing hepatocellular receptor B6 monoclonal antibody Eb6Mab-3 for flow cytometry. Biochemistry and Biophysics Reports. 41. 101960–101960. 2 indexed citations
2.
Tobita, Tadasu, Katsunori Tanaka, Takuya Umemoto, et al.. (2015). SHIZUOKA PREFECTURAL JOINT COMMITTEE OF TRANSFUSION THERAPY: 8-YEAR SURVEY BY SHIZUOKA JOINT COMMITTEE OF TRANSFUSION THERAPY. Japanese Journal of Transfusion and Cell Therapy. 61(4). 480–484. 1 indexed citations
3.
4.
Nakamura, Satoki, Daisuke Yokota, Lin Tan, et al.. (2011). Down‐regulation of Thanatos‐associated protein 11 by BCR‐ABL promotes CML cell proliferation through c‐Myc expression. International Journal of Cancer. 130(5). 1046–1059. 22 indexed citations
5.
Nakamura, Satoki, Lin Tan, Kiyoshi Shibata, et al.. (2011). Transcriptional Repression of Cdc25B by IER5 Inhibits the Proliferation of Leukemic Progenitor Cells through NF-YB and p300 in Acute Myeloid Leukemia. PLoS ONE. 6(11). e28011–e28011. 39 indexed citations
6.
Nakamura, Satoki, Daisuke Yokota, Takaaki Ono, et al.. (2009). Depletion of Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatases 1 and 2 by Bcr-Abl Promotes Chronic Myelogenous Leukemia Cell Proliferation through Continuous Phosphorylation of Akt Isoforms. Journal of Biological Chemistry. 284(33). 22155–22165. 20 indexed citations
7.
Fujisawa, Shinya, Satoki Nakamura, Kensuke Naito, Masahide Kobayashi, & Kazunori Ohnishi. (2008). A variant transcript, e1a3, of the minor BCR–ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literature. International Journal of Hematology. 87(2). 184–188. 21 indexed citations
8.
Nakamura, Satoki, Keiji Okinaka, Takaaki Ono, et al.. (2008). KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells. Leukemia Research. 32(9). 1358–1365. 19 indexed citations
9.
Fujisawa, Shinya, et al.. (2007). Complete Remission Induced by Gemtuzumab Ozogamicin in a Jehovah's Witness Patient with Acute Myelogenous Leukemia. International Journal of Hematology. 85(5). 418–420. 2 indexed citations
10.
Fujisawa, Shinya, et al.. (2006). CD7/CD19 Double-Positive T-Cell Acute Lymphoblastic Leukemia. International Journal of Hematology. 83(4). 324–327. 3 indexed citations
11.
Fujisawa, Shinya, Ryuzo Ohno, Kazuyuki Shigeno, et al.. (2006). Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide. Cancer Chemotherapy and Pharmacology. 59(4). 485–493. 49 indexed citations
12.
Shigeno, Kazuyuki, Hitoshi Yoshida, Ling Pan, et al.. (2003). Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias. Cancer Letters. 213(1). 11–20. 32 indexed citations
13.
Sahara, Naruhiko, Akihiro Takeshita, Kazuyuki Shigeno, et al.. (2002). Clinicopathological and prognostic characteristics of CD56‐negative multiple myeloma. British Journal of Haematology. 117(4). 882–885. 115 indexed citations
14.
Ohnishi, Kazunori, Hitoshi Yoshida, Kohichiro Shigeno, et al.. (2002). Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Leukemia. 16(4). 617–622. 74 indexed citations
15.
Zhang, Wen Jie, Kazunori Ohnishi, Hitoshi Yoshida, et al.. (2000). Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down‐regulation of Bcl‐2 Expression and Modulation of Promyelocytic Leukemia Protein. Japanese Journal of Cancer Research. 91(6). 604–611. 7 indexed citations
16.
17.
18.
Takeshita, Akihiro, Kaori Shinjo, Miho Yamashita, et al.. (1999). Extensive cytogenetic studies of clonality following interferon-α therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic. Leukemia. 13(11). 1749–1753. 6 indexed citations
19.
Ohnishi, Kazunori, Kohichiro Shigeno, Shinya Fujisawa, et al.. (1998). The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia. 12(9). 1383–1391. 140 indexed citations
20.
Fujisawa, Shinya, et al.. (1996). Emergence of Nonalbicans Candida Species in Immunocompromised Leukemia Patients during Fluconazole Treatment. Journal of Infection and Chemotherapy. 2(4). 268–270. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Cicconi Breakdown of academic impact, for papers by Nélida I. Noguera Breakdown of academic impact, for papers by Yi-Cheng Wang Breakdown of academic impact, for papers by Montreh Tavakkoli Breakdown of academic impact, for papers by Tiziana Ottone Breakdown of academic impact, for papers by R. Serafini Breakdown of academic impact, for papers by Kwan Yeung Wong Breakdown of academic impact, for papers by R. Hafter Breakdown of academic impact, for papers by Lingbo Zhang Breakdown of academic impact, for papers by Urszula Kralisz
Rankless by CCL
2026